Business Wire

RSA Announces New Solution to Enhance Security for Microsoft Entra ID

13.11.2025 13:00:00 CET | Business Wire | Press Release

Share

RSA, the security-first identity leader, announced today that RSA® ID Plus for Microsoft, a new solution category that provides an enhanced security layer for Microsoft Entra ID, is now generally available. Now on the Microsoft Azure Marketplace, the first product, RSA ID Plus M1, includes key capabilities that defend organizations from emerging attacks and help them maintain operational continuity in both Microsoft and non-Microsoft environments.

RSA ID Plus for Microsoft M1:

  • Protects resources within and beyond the Microsoft ecosystem: RSA ID Plus provides total coverage for legacy, OT, Microsoft, and non-Microsoft environments, bringing modern MFA and passwordless to data centers, mainframes, macOS, AD-joined devices, Entra-joined PCs and servers (including older OS versions), and other web servers and critical infrastructure that Entra alone can’t reach.
  • Ensures mission-critical resources are always available and always protected: RSA’s unique Hybrid HA architecture and offline capabilities ensure that mission-critical on-prem resources and off-network laptops are always available and always protected even when cloud services are unreachable.
  • Stops attacks that bypass MFA: RSA Help Desk Live Verify stops attacks targeting IT help desk personnel and users. The patent-pending technology uses phishing-resistant, passwordless identity assurance to stop attackers from exploiting weak enrollment and credential processes to launch attacks.
  • Integrates seamlessly with Microsoft: RSA ID Plus works in tandem with Microsoft Entra ID Plan 1 and Plan 2 to close security gaps without complexity.

“High-security industries have unique infrastructures that demand security expertise to maintain operations and defend against new threats,” said RSA CEO Greg Nelson. “RSA ID Plus for Microsoft ensures that banks, hospitals, government agencies, and powerplants can deploy modern security solutions to defend themselves from emerging threats while still ensuring resilient operations.”

“The extraordinary risks that financial services, healthcare, energy, and other highly regulated industries face demand the extraordinary security capabilities that only RSA and Microsoft together can deliver,” said Laura Marx, RSA Chief Marketing and Growth Officer. “With the layered security approach from both RSA and Microsoft, organizations get both the scaled cloud infrastructure and deep identity security expertise they need to stop AI-powered threats, remain operational, and ensure that all users can stay productive.”

Users are invited to demo RSA ID Plus for Microsoft next week at Microsoft Ignite Booth #1826R.

Resources:

RSA ID Plus for Microsoft data sheet

Join RSA at Microsoft Ignite Booth #1826R

RSA Help Desk Live Verify

RSA ID Plus Hybrid Failover

Get RSA ID Plus on the Microsoft Azure Marketplace

About RSA:

RSA provides mission-critical cybersecurity solutions that protect the world’s most security-sensitive organizations. The RSA Unified Identity Platform provides true passwordless identity security, risk-based access, automated identity intelligence, and comprehensive identity governance across cloud, hybrid, and on-premises environments. More than 9,000 high-security organizations trust RSA to manage more than 60 million identities, detect threats, secure access, and enable compliance. For additional information, visit our website to contact sales, find a partner, or learn more about RSA.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251113424287/en/

Contacts

teamrsa@axicom.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press Release

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechnology executive, bringing over two decades of therapeutic and diagnostic R&D experience within industry to Mosaic Therapeutics, with a track record spanning from IND through to NDA/BLA/MAA approval. Most recently he served at BioXcel Therapeutics as EVP, Head of Product Developme

The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press Release

The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights - equipping executives with the perspective needed to make confident, high-stakes decisions. “Through our work we increasingly s

Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 08:00:00 CEST | Press Release

As millions of Europeans2 get ready to enjoy the Easter weekend, new research from Samsung finds Europe’s public spaces have become shared screens: 56% of people say they have accidentally looked at a stranger’s phone, citing public transport as the most likely place to notice someone else’s screen (57%). Nearly one in four Europeans2 (24%) admit to looking at someone else’s phone out of curiosity, exposing a stream of private content from personal photos to bank details. Samsung Electronics surveyed 11,000 Europeans2 to support the launch of the Galaxy S26 Ultra, which introduces a built-in Privacy Display. This new hardware-based technology keeps screen content visible only from the front to protect privacy from side angles, without compromising the viewing experience3. The study further reveals a gap between perceived phone privacy and reality: While 48%* feel their own phone use is private when using it in crowded places, 52%** find it easy to view someone else’s screen in public.

RevolKa Reimagines Antibody Engineering with "RevoAb ® "1.4.2026 06:30:00 CEST | Press Release

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allows researchers worldwide to experience RevolKa’s high-performance antibody design. Key Advantages of RevoAb® Speed: Multiple optimi

Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press Release

NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales, reshaping channel strategies 49% of consumers are willing to pay more for locally made products, ref

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye